4 research outputs found

    Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

    No full text

    ESICM LIVES 2016: part two : Milan, Italy. 1-5 October 2016.

    Get PDF
    Meeting abstrac
    corecore